Back to Search Start Over

Dbl family RhoGEFs in cancer: different roles and targeting strategies.

Authors :
Chen, Xin-Yi
Cheng, Ao-Yu
Wang, Zi-Ying
Jin, Jin-Mei
Lin, Jia-Yi
Wang, Bei
Guan, Ying-Yun
Zhang, Hao
Jiang, Yi-Xin
Luan, Xin
Zhang, Li-Jun
Source :
Biochemical Pharmacology. May2024, Vol. 223, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

[Display omitted] Small Ras homologous guanosine triphosphatase (Rho GTPase) family proteins are highly associated with tumorigenesis and development. As intrinsic exchange activity regulators of Rho GTPases, Rho guanine nucleotide exchange factors (RhoGEFs) have been demonstrated to be closely involved in tumor development and received increasing attention. They mainly contain two families: the diffuse B-cell lymphoma (Dbl) family and the dedicator of cytokinesis (Dock) family. More and more emphasis has been paid to the Dbl family members for their abnormally high expression in various cancers and their correlation to poor prognosis. In this review, the common and distinctive structures of Dbl family members are discussed, and their roles in cancer are summarized with a focus on Ect2, Tiam1/2, P-Rex1/2, Vav1/2/3, Trio, KALRN, and LARG. Significantly, the strategies targeting Dbl family RhoGEFs are highlighted as novel therapeutic opportunities for cancer. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00062952
Volume :
223
Database :
Academic Search Index
Journal :
Biochemical Pharmacology
Publication Type :
Academic Journal
Accession number :
176687222
Full Text :
https://doi.org/10.1016/j.bcp.2024.116141